Status
Conditions
Treatments
About
A monocentric, non-randomized, prospective study in which each patient is his/her own control.
The study investigates 2 methods of blood pressure measurement, within the first 24 hours after reperfusion, i) Continuous measurement of blood pressure with the Clearsight device (Edwards) and ii) intermittent blood pressure measurements with cuff.
Full description
Patients will be followed for 72 hours:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
455 participants in 1 patient group
Loading...
Central trial contact
Amélie Yavchitz, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal